Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|August 4, 2017
National trends in use and costs of oral anticancer drugs in France: An 8-year population-based studyPauline Bosco-Lévy, Paul de Boissieu, Amandine Gouverneur, et al.European Journal of Cancer (Oxford, England : 1990)|April 23, 2024
Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS)Etienne Lengliné, Joachim Baba, Paul de Boissieu, et al.Oncology|January 10, 2015
Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual diseaseSarah Mombelli, Fabrice Kwiatkowski, Catherine Abrial, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 24, 2019
Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional HerniaYohann Renard, Louis de Mestier, Julie Henriques, et al.Journal of Vascular Surgery|November 12, 2019
Intraoperative adverse events and early outcomes of custom-made fenestrated stent grafts and physician-modified stent grafts for complex aortic aneurysmsJean Nicolas Sénémaud, Iannis Ben Abdallah, Paul de Boissieu, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 7, 2021
Mycotic/Infective Native Aortic Aneurysms: Results After Preferential Use of Open Surgery and Arterial AllograftsJoseph Touma, Thibault Couture, Jean-Michel Davaine, et al.Bulletin Du Cancer|February 11, 2018
[Evaluation of the feasibility of a program of adapted physical activity in day hospital of digestive oncology: From the point of view of patients]Céline Crespel, Cloé Brami, Paul de Boissieu, et al.Journal of the International AIDS Society|March 11, 2024
Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort studyVirginie Baltes, Paul de Boissieu, Karen Champenois, et al.Neuroendocrinology|May 10, 2019
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine TumorLouis de Mestier, Thomas Walter, Camille Evrard, et al.Medicine|September 16, 2016
Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort StudyPaul de Boissieu, Moustapha Dramé, François Raffi, et al.Pageof 4